Stephen Gordon, Chief Financial Officer at TransMedics Group, Inc. (TMDX), sold 18,571 shares at $25.01 ($464K) on 2021-02-08, disclosed to the SEC on 2021-02-10.
Open-market sale of $464k TMDX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.01 | 1,429 | $36K | 7.7% |
| 2 | $25.01 | 8,571 | $214K | 46.2% |
| 3 | $25.01 | 8,571 | $214K | 46.2% |
| Total | $25.01 avg | 18,571 | $464K | 100% |
| Filing → |
| TMDX | SELL | 2024-05-08 | $1.9M | — | Filing → |
| TMDX | SELL | 2024-04-02 | $1.1M | — | Filing → |
| TMDX | SELL | 2024-03-12 | $334K | — | Filing → |